|
|
|
|
   |
 |
► Home ﹥News
|
| Activities | | | PharmaEssentia not only has an outstanding performance in Taiwan R&D field but also actively participates numerous international Bio conferences and presentations. The following are the conferences and activities we participate from 2007 to present… read more |
| 11 December, 2009 | | | (Taiwan) PharmaEssentia announces commencement of Phase I clinical trial for its HBV/HCV drug candidate P1101 (PEG-P-IFN-alpha)… read more |
| 28 November, 2009 | | | Dr. ChingLeou Teng was appointed as the Chairman and Dr. KOChung Lin was appointed as CEO of PharmaEssentia by the BOD on Nov 28th, 2009. |
| 12 August, 2009 | | | PharmaEssentia Receives FDA Approval for Hepatitis Drug… read more |
| 4 August, 2009 | | | PharmaEssentia's long-acting HC/BV drug candidate P1101 (PEG-P-IFN-alpha-2b) receives FDA IND approval… read more |
| 14 February, 2009 | | | (Taiwan) PharmaEssentia and ScinoPharm sign supply agreement, announce progress on next-generation EPO… read more |
| 18 June, 2008 | | | PharmaEssentia announces milestone in development of new third-generation interferon hepatitis B and C drug candidate… read more |
| 15 May, 2008 | | | Mixing protein engineering, chemistry for new drugs… read more |
| 14 February, 2008 | | | PharmaEssentia signs CoQ10 manufacturing licensing deal with Malaysia's Black Gold Global… read more |
| 4 July, 2007 | | | PharmaEssentia ramps up int'l networking, announces schedule for new HBV/HCV drug candidate… read more |
| 5 April, 2007 | | | Article in Nature Magazine's 5 April 2008 'Spotlight on Taiwan' special issue… read more |
| 7 August, 2006 | | | PharmaEssentia unveils PharmaQ10 branded CoQ10… read more |
|
 Copyright © 2008 PharmaEssentia Corporation All Rights Reserved. |
|